Inhibition of tau-derived hexapeptide aggregation and toxicity by a self-assembled cyclic <scp>d</scp>,<scp>l</scp>-α-peptide conformational inhibitor

Anna Belostozky, Michal Richman, Elvira Lisniansky, A. Tovchygrechko, Jordan H. Chill, Shai Rahimipour

Chemical Communications · 2018 · 38 citations · 32 references

Concepts

Abstract

Aggregation and accumulation of amyloid β and tau proteins to plaques and neurofibrillary tangles are the key pathogenic events in Alzheimer's disease. Here, we studied the capability of the cyclic d,l-α-peptide CP-2 as a conformational inhibitor of different amyloids to cross-interact with tau-derived AcPHF6 peptide and inhibit its aggregation, membrane perturbation and toxicity.

References

32